For the Inventor, By the Inventor

Enter inventor name

Birmingham, United Kingdom

Mehar Manku

USPTO Granted Patents = 107 (Patent Applications = 60)

EPO Patents = 9 (Patent Applications = 23)

Average Co-Inventor Count = 4.3

ph-index = 32

Forward Citations = 3,745(Granted Patents)

Inventors with similar research interests:

Location History:

Oxford, GB (2012)
Birmingam, GB (2014)
England, GB (2012 - 2021)
Birminham, GB (2018 - 2021)
Birmingham, GB (2012 - 2024)

Company Filing History:

Amarin Pharmaceuticals Ireland Limited

Ds Biopharma Limited

Dignity Sciences Limited

Amarin Pharma, Inc.

Dignity Sciences Limted

Years Active: 2012-2024

Loading Chart...

Loading Chart...

Areas of Expertise:

Triglycerides

Dyslipidemia

Pharmaceutical Compositions

Oxo-Derivatives Of Fatty Acids

Apolipoprotein C-Iii

Nonalcoholic Steatohepatitis

Eicosapentaenoic Acid

Omega-3 Fatty Acids

Cardiovascular Agents

High-Sensitivity C-Reactive Protein

Rlp-C

Dgla

107 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171738 - Compositions and methods for lowering triglycerides (2024-12-24),

2. 12017986 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same (2024-06-25),

3. 11690820 - Methods of treating mixed dyslipidemia (2023-07-04),

4. 11478442 - Pharmaceutical compositions comprising DGLA and use of same (2022-10-25),

5. 11464757 - Compositions and methods for lowering triglycerides (2022-10-11),

6. 11439618 - Compositions and methods for lowering triglycerides (2022-09-13),

7. 11400069 - Methods of treating mixed dyslipidemia (2022-08-02),

8. 11291643 - Methods of treating hypertriglyceridemia (2022-04-05),

9. 11285127 - Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy (2022-03-29),

10. 11229618 - Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy (2022-01-25),

11. 11213504 - Stable pharmaceutical composition and methods of using same (2022-01-04),

12. 11185525 - Methods of reducing apolipoprotein C-III (2021-11-30),

13. 11179362 - Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy (2021-11-23),

14. 11154526 - Methods of treating mixed dyslipidemia (2021-10-26),

15. 11147787 - Stable pharmaceutical composition and methods of using same (2021-10-19),

Title: The Inventive Journey of Mehar Manku

Introduction:

Mehar Manku, a prolific inventor based in Birmingham, GB, has left a lasting impact on the field of healthcare with his innovative patents. With a total of 105 patents to his name, Manku's contributions have significantly advanced the treatment of various health conditions. Let's delve into his latest patents, career highlights, and collaborations.

Latest Patents:

Manku's recent patents showcase his expertise in developing groundbreaking pharmaceutical compositions. One of his latest inventions involves methods for treating mixed dyslipidemia with ethyl eicosapentaenoate. Another notable patent focuses on orally deliverable pharmaceutical compositions containing DGLA for treating a range of conditions and disorders.

Career Highlights:

Throughout his career, Mehar Manku has been associated with prominent companies in the pharmaceutical industry. He has made significant contributions during his time at Amarin Pharmaceuticals Ireland Limited and Ds Biopharma Limited. His innovative spirit and dedication to advancing medical treatments have garnered him recognition within the industry.

Collaborations:

Manku's collaborative efforts have also been instrumental in his success as an inventor. Working alongside coworkers like Pierre Wicker and Paresh Soni, he has brought a multidisciplinary approach to his research and development projects. These collaborations have resulted in the creation of impactful solutions that benefit patients worldwide.

Conclusion:

In conclusion, Mehar Manku's journey as an inventor is characterized by a relentless pursuit of innovation in healthcare. With a remarkable portfolio of patents and a history of fruitful collaborations, Manku continues to push the boundaries of medical science. His contributions serve as a testament to the power of creativity and teamwork in driving progress within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…